Filter
1237
Filtered Results: 1237
Text search:
booster
Featured
Recommendations
92
New Publications
313
Language
Document type
No document type
625
Studies & Reports
258
Guidelines
154
Strategic & Response Plan
64
Fact sheets
40
Manuals
39
Situation Updates
21
Training Material
17
Infographics
7
Brochures
6
Resource Platforms
4
Videos
2
Countries / Regions
Global
70
India
47
South Africa
31
Syria
26
Sierra Leone
23
Liberia
23
Nigeria
20
Uganda
20
Kenya
19
Africa
19
Ukraine
18
Western and Central Europe
16
Tanzania
15
Zambia
15
Nepal
14
Latin America and the Carribbean
14
Congo, Democratic Republic of
14
Philippines
13
Guinea
12
Germany
12
Myanmar / Burma
12
Namibia
11
Ethiopia
11
Rwanda
10
Zimbabwe
10
Bangladesh
10
Mozambique
9
Asia
9
East and Southern Africa
9
Brazil
9
Ghana
8
Senegal
8
South–East Asia Region
8
Yemen
8
Colombia
7
Venezuela
7
South Sudan
7
Argentina
6
Eastern Europe
6
Lesotho
5
Malawi
5
West and Central Africa
5
Middle East and North Africa
5
Indonesia
5
Cameroon
4
Afghanistan
4
Jordan
4
Western Pacific Region
4
Central African Republic
4
Pakistan
4
Benin
3
China
3
Chile
3
Burkina Faso
3
Haiti
3
Lebanon
3
Moldova
3
Sudan
3
Botswana
3
Eswatini/ Swaziland
3
Thailand
2
Turkey
2
Estonia
2
Cambodia
2
Eastern Europe and Central Asia
2
United Kingdom
2
Southern Africa
2
Russia
2
Greece
2
Somalia
2
Ecuador
2
Madagascar
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Gambia
1
Iran
1
Albania
1
Fiji
1
Laos
1
Niger
1
Peru
1
USA
1
Hungary
1
Lithuania
1
Mauritius
1
Bolivia
1
Vietnam
1
Sri Lanka
1
Egypt
1
Romania
1
Palestine
1
Poland
1
Chad
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
425
Clinical Guidelines
124
Women & Child Health
67
Key Resources
57
Public Health
52
Capacity Building
17
Pharmacy & Technologies
5
Toolboxes
COVID-19
167
HIV
123
Mental Health
62
Conflict
58
TB
56
Planetary Health
51
Refugee
41
NTDs
36
Ebola & Marburg
34
Rapid Response
26
Health Financing Toolbox
26
Caregiver
24
Polio
23
Disability
22
AMR
21
Natural Hazards
19
Pharmacy
16
Global Health Education
16
NCDs
9
Cholera
6
Social Ethics
3
Zika
3
Specific Hazards
2
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
September 2021
September 2021
Rivercess, Liberia, April 25, 2024 - Liberia marks a monumental milestone in its battle against malaria
as it launches the highly anticipated RTS,S malaria vaccine today, coinciding with World Malaria Day,
commemorated under the theme: Health Equity, Gender, and Human Rights: Accelerating the Figh...
Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who...
Donor funding for HIV programs has increased rapidly over the past decade, raising questions about whether other health services in recipient-country health systems are being crowded out or strengthened. This article--an investigation of the impacts of increased HIV donor funding on non-HIV health s...
Guidelines for the Vaccination Scheme against
COVID 19: Booster Dose Health Personnel
Memorandum: Recommendation of interval for the application of the booster dose of COVID-19 vaccines
COVID-19 Social Media Support Kit
recommended
These campaign support materials have been developed and shared to bolster national initiatives and outreach campaigns in AU Member States. The message will continue to evolve as the COVID-19 pandemic progresses and as understanding of optimal responses develop further.
You can download the toolkit...
How much protection does the current batch of COVID-19 vaccines provide us? Would you need a booster shot for new variants? What does science and evidence tell us about mass gatherings and the spread of COVID-19?
WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5 this week.
Neonatal tetanus (NT), a severe newborn illness from the toxigenic strains of Clostridium tetani, persists in middle- and low-income countries due to non-sterile childbirth practices. Unlike smallpox and polio, tetanus cannot be eradicated: Clostridium tetani spores exist in the environment, and ani...
Covid-19 Test to Treat Guidelines
recommended
n response to the outbreak, the Africa Centres for Disease Control and Prevention (Africa CDC) has been supporting African Union Member States in responding to the COVID-19 pandemic through a variety of interventions such as non-pharmaceutical interventions, quarantine, testing, isolation, contact t...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be vaccinated. The Essential Immunization Recovery Plan...
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But ...
299 deaths have been recorded and 329 people are still missing, according to the Government.
• Latest assessments indicate that the homes of some tens of thousands of people have been destroyed or damaged beyond habitability. Most of these people are staying with hosts in the extended community.
...
In 2021 ACT-Accelerator will intensify its drive for equity and scale in the delivery of essential COVID-19 tools, while managing emerging viral risks. To address these major shifts and maintain momentum, ACT-Accelerator has defined four strategic priorities for 2021: Rapidly scale up the delivery o...
Global growth is projected to slow significantly amid high inflation, tight monetary policy, and more restrictive credit conditions. The possibility of more widespread bank turmoil and tighter monetary policy could result in even weaker global growth and lead to financial dislocations in the most vu...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
